Cargando…

EFFICACY AND SAFETY OF CELECOXIB COMPARED WITH PLACEBO AND ETODOLAC FOR ACUTE POSTOPERATIVE PAIN: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, CONTROLLED TRIAL

Celecoxib is a nonsteroidal anti-inflammatory drug (selective cyclooxygenase-2 inhibitor) that is widely used. The efficacy and safety of celecoxib for treatment of acute postoperative pain were evaluated in Japanese patients. The objective was to assess whether celecoxib showed superiority over pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	ISHIGURO, NAOKI, HANAOKA, AKIO, OKADA, TOSHIYUKI, ITO, MASANORI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nagoya University 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361510/ https://www.ncbi.nlm.nih.gov/pubmed/25797973

Ejemplares similares

Comparison of safety and analgesic efficacy of diclofenac sodium with etodolac after surgical extraction of third molars: a randomized, double-blind, double-dummy, parallel-group study
por: Vaghela, Jitendra H., et al.
Publicado: (2020)

Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: A randomised, double-blind, crossover study
por: Akbulut, Nihat, et al.
Publicado: (2014)

Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis
por: Kaur, Navjot, et al.
Publicado: (2013)

R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac
por: Roberts, JoAnn S., et al.
Publicado: (2022)

Etodolac and the risk of acute pancreatitis
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Elmets, Craig A., et al.
Publicado: (2010)

Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study
por: Munjal, Sagar, et al.
Publicado: (2017)

Pregabalin to improve postoperative recovery in bariatric surgery: a parallel, randomized, double-blinded, placebo-controlled study
por: Martins, Marcelo J, et al.
Publicado: (2018)

Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study
por: Zhang, Mei, et al.
Publicado: (2019)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
por: Lipton, Richard B, et al.
Publicado: (2021)

Efficacy, Safety, and Tolerability of ONO‐4474, an Orally Available Pan‐Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo‐Controlled, Double‐Blind, Parallel‐Group Comparative Study
por: Ishiguro, Naoki, et al.
Publicado: (2019)

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations
por: Gouda, Ayman A, et al.
Publicado: (2008)

Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
por: Zhuang, Qianyu, et al.
Publicado: (2020)

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
por: Zwiep, J.C., et al.
Publicado: (2022)

Efficacy and safety of diacerein and celecoxib combination therapy for knee osteoarthritis: A double-blind, randomized, placebo-controlled prospective study
por: Youn, Sangah, et al.
Publicado: (2023)

Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
por: Zhuang, Qianyu, et al.
Publicado: (2016)

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study
por: Sandrini, Giorgio, et al.
Publicado: (2011)

The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial
por: Hua, Wei, et al.
Publicado: (2015)

Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial
por: Zhang, Xian-Long, et al.
Publicado: (2016)

Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
por: Caponnetto, Pasquale, et al.
Publicado: (2023)

Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
Publicado: (2020)

Children’s International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis
por: Burke, Carol A, et al.
Publicado: (2017)

Healing rates after rotator cuff repair for patients taking either celecoxib or placebo: a double-blind randomized controlled trial
por: Burns, Katherine A., et al.
Publicado: (2020)

Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation
por: Shilakari Asthana, Gyati, et al.
Publicado: (2016)

Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study
por: Murto, Kimmo, et al.
Publicado: (2015)

Randomized, double-blind, placebo-controlled, parallel-group study of the effect of Lactobacillus paracasei K71 intake on salivary release of secretory immunoglobulin A
por: SAITO, Yuhi, et al.
Publicado: (2016)

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
por: Kinoshita, Taku, et al.
Publicado: (2022)

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial
por: Lin, Jianguo, et al.
Publicado: (2023)

Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial
por: Martinez, Fernando J., et al.
Publicado: (2023)

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial
por: Hüttner, Felix J, et al.
Publicado: (2020)

A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN(® )administered orally
por: Solomon, Todd M, et al.
Publicado: (2015)

The effect of 24-week continuous intake of quercetin-rich onion on age-related cognitive decline in healthy elderly people: a randomized, double-blind, placebo-controlled, parallel-group comparative clinical trial
por: Nishihira, Jun, et al.
Publicado: (2021)

A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study
por: Majd, Marzieh, et al.
Publicado: (2015)

Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study
por: Sekikawa, Takahiro, et al.
Publicado: (2023)

Efficacy and Safety of 1 % Terbinafine Film-Forming Solution in Chinese Patients with Tinea Pedis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study
por: Li, Ruo Yu, et al.
Publicado: (2014)

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
por: Xiao, Shifu, et al.
Publicado: (2021)

Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
por: Kinoshita, Taku, et al.
Publicado: (2022)

Randomised, double-blind, parallel group, placebo-controlled study to evaluate the analgesic efficacy and safety of VVZ-149 injections for postoperative pain following laparoscopic colorectal surgery
por: Nedeljkovic, Srdjan S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rh2u63itd29fulgv5ls0fm31g3